Abstract | BACKGROUND: Human umbilical cord mesenchymal stem cells (hUCMSCs) have high therapeutic value in cancer treatment. We have found that pre-activating hUCMSCs with IL-1β promotes tumor necrosis factor-related apoptosis inducing ligand (TRAIL) expression and facilitates anti- tumor effect. Furthermore, embelin has been found to induce apoptosis of different cancer cell lines by upregulating the expression of TRAIL receptor 1 (DR4) and TRAIL receptor 2 (DR5). This study investigated whether IL-1β induced TRAIL-expressing hUCMSCs, in combination with low-dose embelin, could further induce apoptosis in breast cancer cell lines. MATERIALS AND METHODS: MTT assay was used to examine the cytotoxicity of embelin in MDA-MB-231 and MCF-7. To detect the interested protein expression in cells, Western blot and cell immunofluorescence were used to double-confirm the observed results. Annexin V/PI apoptosis assay was detected by flow cytometry to analyze the apoptosis rate of embelin treated breast cancer cell lines and the effect of co-culturing with breast cancer cells and hUCMSCs. RESULTS: Using Western blot and immunofluorescence, we found that breast cancer cell lines treated with low-dose embelin (2.5-5 μM) increased the expression of apoptosis-related receptor DR4, DR5 and the cleaved caspase 8, 9 and 3. Moreover, TRAIL expression was enhanced in IL-1β induced hUCMSCs. Combining these observations, we expected that coculturing IL-1β induced hUCMSCs with low dose embelin treated MDA-MB-231 and MCF-7 cells might enhance the apoptosis of breast cancer cells. We confirmed via flow cytometry that coculture of IL-1β induced TRAIL-expressing hUCMSCs and embelin treated MDA-MB-231 and MCF-7 cells enhances the apoptosis rate of these breast cancer cells. CONCLUSION: We found that embelin upregulated the expression of DR4 and DR5 to increase the TRAIL-mediated apoptosis in breast cancer cell lines. Low dose embelin treated breast cancer cell lines in combination with IL-1β induced TRAIL-expressing hUCMSCs may become a potential anti- tumor therapy.
|
Authors | Jui-Wen Teng, Eric Hung, Jiann-Ming Wu, Ya-Han Liang, Yun-Hsuan Chiu, Yeu-Sheng Tyan, Hwai-Shi Wang |
Journal | Asian Pacific journal of cancer prevention : APJCP
(Asian Pac J Cancer Prev)
Vol. 24
Issue 4
Pg. 1297-1305
(Apr 01 2023)
ISSN: 2476-762X [Electronic] Thailand |
PMID | 37116152
(Publication Type: Journal Article)
|
Chemical References |
- embelin
- Ligands
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- TNF-Related Apoptosis-Inducing Ligand
- Tumor Necrosis Factor-alpha
- Interleukin-1beta
|
Topics |
- Female
- Humans
- Apoptosis
- Breast Neoplasms
(drug therapy)
- Cell Line, Tumor
- Ligands
- MCF-7 Cells
- Mesenchymal Stem Cells
(metabolism)
- Receptors, TNF-Related Apoptosis-Inducing Ligand
(metabolism)
- TNF-Related Apoptosis-Inducing Ligand
(pharmacology)
- Tumor Necrosis Factor-alpha
- Interleukin-1beta
(pharmacology)
|